Diagnostics services provider Dr. Lal PathLabs (NSE:LALPATHLAB, BOM:539524) allotted around 83.8 million bonus equity shares of face value of 10 Indian rupees in the ratio of 1:1, according to a Monday filing to the Indian bourses.
The company allotted one equity share of 10 rupees each for each equity share of 10 rupees held by the eligible shareholders.
Following the allotment of the bonus equity shares, the post-bonus equity capital has increased to 1.68 billion rupees, comprising 167.6 million equity shares of 10 rupees each.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments